Literature DB >> 15970699

PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells.

Janusz Puc1, Ramon Parsons.   

Abstract

CHK1 is an essential kinase involved in the regulation of the cell cycle progression and preservation of genomic integrity. Inhibition of CHK1 leads to the accumulation of double-stranded DNA breaks. Loss of PTEN impairs CHK1-mediated checkpoint activation due to cytoplasmic sequestration of ubiquitinated CHK1. Here, we provide evidence that another consequence of reduced CHK1 function in PTEN deficient cells is the accumulation of double-stranded DNA breaks. Moreover, we show that the site of CHK1 ubiquitination (K274) is near the site of AKT phosphorylation (S280). Overall, these data demonstrate that lack of PTEN generates DNA damage due to inappropriate inactivation of CHK1.DNA damage due to the loss of PTEN is likely to stimulate tumor development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970699     DOI: 10.4161/cc.4.7.1795

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation.

Authors:  Byeong Hyeok Choi; Yan Chen; Wei Dai
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

2.  Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53.

Authors:  T Fishler; Y-Y Li; R-H Wang; H-S Kim; K Sengupta; A Vassilopoulos; T Lahusen; X Xu; M-H Lee; Q Liu; S-J Elledge; T Ried; C-X Deng
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

Review 3.  PTEN in DNA damage repair.

Authors:  Mei Ming; Yu-Ying He
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

4.  A critical role of the PTEN/PDGF signaling network for the regulation of radiosensitivity in adenocarcinoma of the prostate.

Authors:  Michael Christensen; Abdo J Najy; Michael Snyder; Lisa S Movilla; Hyeong-Reh Choi Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-01       Impact factor: 7.038

5.  PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.

Authors:  M Katie Conley-LaComb; Wei Huang; Shihua Wang; Dongping Shi; Young Suk Jung; Abdo Najy; Rafael Fridman; R Daniel Bonfil; Michael L Cher; Yong Q Chen; Hyeong-Reh Choi Kim
Journal:  Am J Pathol       Date:  2011-12-28       Impact factor: 4.307

6.  Combined haploinsufficiency and genetic control of the G2/M checkpoint in irradiated cells.

Authors:  Erik F Young; Lubomir B Smilenov; Howard B Lieberman; Eric J Hall
Journal:  Radiat Res       Date:  2012-05-18       Impact factor: 2.841

7.  Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage response.

Authors:  Elda Grabocka; Yuliya Pylayeva-Gupta; Mathew J K Jones; Veronica Lubkov; Eyoel Yemanaberhan; Laura Taylor; Hao Hsuan Jeng; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

8.  EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.

Authors:  Li Li; Amalia Dutra; Evgenia Pak; Joseph E Labrie; Rachel M Gerstein; Pier Paolo Pandolfi; Larry D Recht; Alonzo H Ross
Journal:  Neuro Oncol       Date:  2008-09-23       Impact factor: 12.300

9.  Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1.

Authors:  Yu-Che Cheng; Tsong-Yu Lin; Sheau-Yann Shieh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

10.  Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis.

Authors:  Justin G Madson; David T Lynch; Jessica Svoboda; Rebecca Ophardt; Jodi Yanagida; Sumanth K Putta; Andrew Bowles; Carol S Trempus; Raymond W Tennant; Laura A Hansen
Journal:  Am J Pathol       Date:  2009-04-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.